Clopra and Hypercoagulation - a phase IV clinical study of FDA data

Summary:

Hypercoagulation is reported as a side effect among people who take Clopra (metoclopramide hydrochloride), especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years also take Levaquin, and have Nausea.

The phase IV clinical study analyzes which people have Hypercoagulation when taking Clopra. It is created by eHealthMe based on reports of 80,974 people who have side effects when taking Clopra from the FDA, and is updated regularly.

What is Clopra?

Clopra has active ingredients of metoclopramide hydrochloride. eHealthMe is studying from 81,430 Clopra users. Check the latest studies of Clopra.

What is Hypercoagulation?

Hypercoagulation (increased tendency for clotting of the blood) is found to be associated with 392 drugs and 537 conditions by eHealthMe. Check the latest studies of Hypercoagulation.

On Jun, 22, 2026

80,974 people reported to have side effects when taking Clopra.
Among them, 13 people (0.02%) have Hypercoagulation.

Among these 13 people:

How long have people been on Clopra when they have Hypercoagulation? *

What is the gender of people who have Hypercoagulation when taking Clopra? *

female: 91.67 %
male: 8.33 %

What is the age of people who have Hypercoagulation when taking Clopra? *

What are other drugs people take besides Clopra? *

What are other side effects people have besides Hypercoagulation? *

Fatigue (feeling of tiredness): 7 people, 53.85%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 6 people, 46.15%
Nausea (feeling of having an urge to vomit): 6 people, 46.15%
Enlarged Heart: 6 people, 46.15%
Pleural Effusion (water on the lungs): 6 people, 46.15%
Weakness: 6 people, 46.15%
Weight Decreased: 5 people, 38.46%
Hypotension (abnormally low blood pressure): 5 people, 38.46%
Hypoglycemia (low blood sugar): 5 people, 38.46%
Rashes (redness): 5 people, 38.46%

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 5 people, 38.46%
Pain: 3 people, 23.08%
Osteoporosis (bones weak and more likely to break): 3 people, 23.08%
Bone Loss: 3 people, 23.08%
Osteoma (a new piece of bone usually growing on another piece of bone, typically the skull. it is a benign tumour): 2 people, 15.38%
Pancreatic Carcinoma (pancreatic cancer): 2 people, 15.38%
Quit Smoking: 1 person, 7.69%
Diabetic Gastroparesis (paralysis of the muscles of the stomach caused by diabetes): 1 person, 7.69%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 7.69%
Benign Bone Neoplasm (benign (non-cancerous) tumours of the bone): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Clopra and have Hypercoagulation?

- Check whether Hypercoagulation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clopra:

Clopra (81,430 reports)

Browse all side effects of Clopra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypercoagulation:

Hypercoagulation (392 drugs)

Browse all the conditions that are associated with Hypercoagulation:

Hypercoagulation (537 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on metoclopramide hydrochloride (the active ingredients of Clopra) and Clopra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.